Webinar: Injecting Neural Stem Cells into ALS Patients: Results of a Phase 1 Trial | Jonathan Glass
Title: Lumbar Intraspinal Injection of Neural Stem Cells in Patients with ALS: Results of a Phase I Trial in 12 Patients
Speaker: Jonathan D. Glass, M.D.
Professor, Neurology and Pathology, Emory University School of Medicine
Presented April 15, 2013
This presentation was part of the webinar event, “Clinical Trials: Moving Stem Cell based Therapies to the Clinic – Presentations from FDA and Leading Experts” hosted by CIRM and the Regenerative Medicine Consortium
The focus of this webinar is on the Lessons Learned from IND/Phase I trials including overcoming the challenges, and addressing the regulatory issues, as stem cell based therapies move towards the clinic.
To learn more about CIRM-funded progress toward therapies, click here.